Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Ocular Therapeutix™ Updates Monthly In-Market Unit Sales of DEXTENZA® Billable Inserts …,

Ocular Therapeutix’s first commercial drug product, DEXTENZA®, … assets currently in Phase 1 clinical trials include OTX-TKI (axitinib …, Ocular Therapeutix’s first commercial drug product, DEXTENZA®, … assets currently in Phase 1 clinical trials include OTX-TKI (axitinib …, Read More

Scroll to Top